http://orcid.org/0000-0001-7388-2655
About the Authors
- Lisa L. Ross
-
Roles Conceptualization, Supervision, Writing – original draft, Writing – review & editing
* E-mail: lisa.l.ross@viivhealthcare.com
Affiliation Medical Affairs, ViiV Healthcare, Research Triangle Park, NC, United States of America
- A. Sarah Walker
-
Roles Data curation, Formal analysis, Resources, Validation, Writing – original draft, Writing – review & editing
Affiliation Medical Research Council Clinical Trials Unit, University College, London, United Kingdom
- Yu Lou
-
Roles Conceptualization, Formal analysis, Validation, Writing – original draft, Writing – review & editing
Affiliation Statistics, PAREXEL International, Durham, NC, United States of America
- Allan R. Tenorio
-
Roles Conceptualization, Writing – original draft, Writing – review & editing
Affiliation Physicians Group, ViiV Healthcare, Research Triangle Park, NC, United States of America
- Diana M. Gibb
-
Roles Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing
Affiliation Medical Research Council Clinical Trials Unit, University College, London, United Kingdom
- Julia Double
-
Roles Conceptualization, Writing – original draft, Writing – review & editing
Affiliation Safety and Medical Governance, GlaxoSmithKline, Stockley Park, United Kingdom
- Charles Gilks
-
Roles Funding acquisition, Project administration, Resources, Supervision, Writing – original draft
Affiliation School of Population Health, University of Queensland, Brisbane, Australia
- Cynthia C. McCoig
-
Roles Conceptualization, Writing – original draft, Writing – review & editing
Affiliation Physicians Group, ViiV Healthcare, Tres Cantos, Spain
- Paula Munderi
-
Roles Investigation, Project administration, Writing – original draft, Writing – review & editing
Affiliation HIV Care Research Programme, MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
- Godfrey Musoro
-
Roles Investigation, Project administration, Writing – original draft, Writing – review & editing
Affiliation Department of Medicine, University of Zimbabwe, Harare, Zimbabwe
- Cissy M. Kityo
-
Roles Investigation, Project administration, Writing – original draft, Writing – review & editing
Affiliation HIV Clinical Trials Unit, Joint Clinical Research Centre, Kampala, Uganda
- Heiner Grosskurth
-
Roles Investigation, Project administration, Supervision, Writing – original draft, Writing – review & editing
Affiliation HIV Care Research Programme, MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
- James Hakim
-
Roles Funding acquisition, Investigation, Project administration, Supervision, Writing – original draft, Writing – review & editing
Affiliation Department of Medicine, University of Zimbabwe, Harare, Zimbabwe
- Peter N. Mugyenyi
-
Roles Funding acquisition, Investigation, Project administration, Writing – original draft, Writing – review & editing
Affiliation HIV Clinical Trials Unit, Joint Clinical Research Centre, Kampala, Uganda
- Amy Cutrell
-
Roles Formal analysis, Validation, Writing – original draft, Writing – review & editing
Affiliation Healthcare Statistics, ViiV Healthcare, Research Triangle Park, NC, United States of America
- Teodora Perger
-
Roles Conceptualization, Writing – original draft, Writing – review & editing
Affiliation Safety and Pharmacovigilance, ViiV Healthcare, London, United Kingdom
- Mark S. Shaefer
-
Roles Conceptualization, Writing – original draft, Writing – review & editing
Affiliation Medical Affairs, ViiV Healthcare, Research Triangle Park, NC, United States of America
Competing Interests
We have the following interests: LLR, ART, CCM, AC, TP, and MSS are employees of ViiV Healthcare and own stock in GlaxoSmithKline. ASW discloses receiving grant funding for the DART trial from the UK Medical Research Council, the UK Department for International Development, and the Rockefeller Foundation; receiving nonfinancial support from ViiV Healthcare, GlaxoSmithKline, Gilead Sciences, and Boehringer Ingelheim, all of which donated drugs for the DART trial; receiving funding from Gilead Sciences for teaching courses on Critical Appraisal; and receiving funding from Janssen for sitting on a Data Safety Monitoring Board. YL was an employee of PAREXEL International and owns stock in GlaxoSmithKline. DMG discloses nonfinancial support from GlaxoSmithKline, Gilead, and Boehringer Ingelheim, all of which provided drugs for the DART trial, and nonfinancial support from Gilead, ViiV Healthcare, CIPLA, and Mylan, all of which donated drugs for HIV trials outside of the submitted work. JD is an employee of and owns stock in GlaxoSmithKline. CG, PM, GM, and CMK have nothing to disclose. HG discloses receiving funds in the form of a grant from MRC/UVRI Uganda Research Unit on AIDS, during which time HG was the Unit Director and drew a salary from MRC (UK) during the conduct of the study. JH and PNM have nothing to disclose. This retrospective analysis of data through 96 weeks from the DART trial was supported by ViiV Healthcare using data provided by the DART trial sponsors, the Medical Research Council of the United Kingdom. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.